Literature DB >> 35111627

Ocular microvascular alteration in Sjögren syndrome.

Qi-Chen Yang1,2, Fan Yao1, Qiu-Yu Li1, Min-Jie Chen1, Li-Juan Zhang1, Hui-Ye Shu1, Rong-Bin Liang1, Yi-Cong Pan1, Qian-Min Ge1, Yi Shao1.   

Abstract

BACKGROUND: Sjögren syndrome (SjS) is a systemic disease affecting exocrine, including ocular lacrimal, glands. It is uncertain whether ocular microvascular alterations are associated with this disease. In this study, we evaluated retinal and conjunctival microvascular changes in SjS patients using optical coherence tomography angiography (OCTA).
METHODS: Twelve SjS patients (24 eyes) and 12 normal controls (24 eyes) were recruited to this study. Three-dimensional conjunctival and retinal OCTA images of each eye were captured and microvascular density was calculated. Each image was analyzed by retinal area based on the early treatment of diabetic retinopathy study method (R, S, L, and I) hemisphere segmentation method (SR, SL, IL, and IR); and central wheel division method (C1-C6). Correlation analyses were used to look for associations between retinal and conjunctival microvascular densities.
RESULTS: Superficial and deep retinal layer microvascular density was decreased in SjS patients compared with normal controls (P<0.05). This significant difference was found in both superficial and deep layers in S, L, SL, IL and C1-C3 regions, and additionally in the I and SR regions in the superficial layer. Conversely, in the conjunctiva microvascular density was higher in SjS patients than in controls. In SjS patients, a significant negative correlation was found between conjunctival and both superficial (r=-0.641; P=0.025) and deep (r=-0.958; P<0.0001) microvascular densities.
CONCLUSIONS: The changed microvascular densities measured in deep and superficial retinal layers and in the conjunctiva demonstrate that OCTA is a promising method in differentiating the eyes from those with SjS. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Sjögren syndrome (SjS); optical coherence tomography angiography; retinal microvascular density

Year:  2022        PMID: 35111627      PMCID: PMC8739119          DOI: 10.21037/qims-21-234

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  40 in total

1.  Progressive retinal neurodegeneration and microvascular change in diabetic retinopathy: longitudinal study using OCT angiography.

Authors:  Kiyoung Kim; Eung Suk Kim; Do Gyun Kim; Seung-Young Yu
Journal:  Acta Diabetol       Date:  2019-08-10       Impact factor: 4.280

2.  RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY.

Authors:  Lei Ye; Shuang-Shuang Zhou; Wen-Long Yang; Jing Bao; Nan Jiang; You-Lan Min; Qing Yuan; Gang Tan; Mei Shen; Yi Shao
Journal:  Endocr Pract       Date:  2018-07       Impact factor: 3.443

3.  Corneal melt as the initial presentation of primary Sjögren's syndrome.

Authors:  F B Vivino; P Minerva; C H Huang; S E Orlin
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

4.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

5.  Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.

Authors:  P Brito-Zerón; B Kostov; R Solans; G Fraile; C Suárez-Cuervo; A Casanovas; F J Rascón; R Qanneta; R Pérez-Alvarez; M Ripoll; M Akasbi; B Pinilla; J A Bosch; J Nava-Mateos; B Díaz-López; M L Morera-Morales; H Gheitasi; S Retamozo; M Ramos-Casals
Journal:  Ann Rheum Dis       Date:  2014-11-28       Impact factor: 19.103

6.  Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.

Authors:  M Sisto; S Lisi; D D Lofrumento; M D'Amore; M A Frassanito; D Ribatti
Journal:  Genes Immun       Date:  2012-04-19       Impact factor: 2.676

7.  Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies.

Authors:  Paola Conigliaro; Paola Triggianese; Gianluca Draghessi; Claudia Canofari; Gianluca Aloe; Maria Sole Chimenti; Claudia Valeri; Carlo Nucci; Roberto Perricone; Massimo Cesareo
Journal:  Int Arch Allergy Immunol       Date:  2018-06-14       Impact factor: 2.749

Review 8.  Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis.

Authors:  Baodong Qin; Jiaqi Wang; Zaixing Yang; Min Yang; Ning Ma; Fenglou Huang; Renqian Zhong
Journal:  Ann Rheum Dis       Date:  2014-06-17       Impact factor: 19.103

9.  Relationship between retinal morphological findings and autoantibody profile in primary Sjögren's syndrome.

Authors:  Jee Myung Yang; Hwan Heo; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2014-06-03       Impact factor: 2.447

Review 10.  Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.

Authors:  Tim Both; Virgil A S H Dalm; P Martin van Hagen; Paul L A van Daele
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.